October 6, 2026Stocks·Bullish·company
Zoetis says 25% of Simparica Trio-treated dogs had adult heartworms vs. 75% on NexGard Plus in drug-resistant heartworm study
Zoetis says in a drug-resistant heartworm study, 25% of dogs treated with Simparica Trio had adult heartworms versus 75% on NexGard Plus.
Detected & updated continuously · Source: Nebula
Story subjects